http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102574864-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862ae7c1e54239070adac80edbab6e31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f5b4e3ee32eb183cc944b6c5fb3e109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5780d1e213903d9c4758421dc56f00b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0382a654bc15d245db186df0a6f542c2 |
| publicationDate | 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102574864-B |
| titleOfInvention | Fused aminodihydropyrimidone derivatives |
| abstract | A compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein ring A is a C6-14 aryl group or the like, L is CNR<e>CO- or the like (wherein R<e> is a hydrogen atom or the like), ring B is a C6-14 aryl group or the like, X is a C1-3 alkylene group or the like, Y is a single bond or the like, Z is a C1-3 alkylene group or the like, R<1>, R<2> and R<x> are each independently a hydrogen atom or the like, and R<3>, R<4>, R<5> and R<6> are independently a hydrogen atom, a halogen atom or the like, has an A beta production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by A beta and typified by Alzheimer-type dementia. |
| priorityDate | 2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 361.